Is Medicus Pharma Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Medicus Pharma Ltd (MDCX.V) is currently classified as NOT HALAL as of January 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Medicus Pharma Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Medicus Pharma Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Medicus Pharma Ltd?

Muslim investors may consider investing in Medicus Pharma Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Medicus Pharma Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Medicus Pharma Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Medicus Pharma Ltd updated?

The Shariah compliance status of Medicus Pharma Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Medicus Pharma Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Medicus Pharma Ltd?

You can check the latest Shariah compliance status of Medicus Pharma Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

MDCX.V Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: January 21, 2025

Report Source: 2024 3rd Quarter Report

Medicus Pharma Ltd. Stock Analysis MDCX.V

Canada Health Care Micro Cap Report: Q3, 2024

Medicus Pharma Ltd is a CA-based company operating in Biotechnology industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2023-10-11. Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets. Its subsidiaries include SkinJect, Inc, and Medicus Pharma Inc. The Company’s wholly owned subsidiary, SkinJect, Inc (SkinJect), is focused on commercializing a novel, non-invasive treatment for basal cell skin cancer using a patented dissolvable microneedle patch to deliver chemotherapeutic agent to eradicate tumor cells. The Company’s wholly owned subsidiaries are focused on the development of a drug delivery system using a dissolvable microneedle array for the treatment of certain skin cancers. The firm investigates opportunities across all therapeutic areas where an unmet need exists for improved patient safety and efficacy. The firm is actively exploring expanding its drug development pipeline through qualified and accretive acquisitions and partnerships.

Key Statistics of Medicus Pharma Ltd (MDCX.V)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$5.69$5.91

Today's Open

$5.91

Volume

700.00

P/E Ratio (TTM)

52 Week Range

$3.84$5.91

Market Cap

67.96M

Avg. Volume

1985.08

Dividend Yield

Financial Metrics & Statements of Medicus Pharma Ltd (MDCX.V)

FAQ's for Medicus Pharma Ltd (MDCX.V)

According to Musaffa’s Shariah screening methodology, Medicus Pharma Ltd (MDCX.V) is currently classified as NOT HALAL as of January 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.